Internal Medicine, Medical Oncology · Los Angeles, CA
NPI
1285957589
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8700 Beverly Boulevard, Room 5512
Los Angeles, CA, 90048
Phone (310) 423-5585
Groups this clinician bills Medicare through
Medicare paid, 2024
$271K
11,646 services
Medicare patients, 2024
226
Average age 73
Drug cost, 2024
$2.2M
554 prescriptions
Company payments, 2025
$24.84
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia A Young was code 85025 (blood count), 245 times for 125 patients. In total Patricia A Young billed 11,646 services in 95 codes, and Medicare paid $271K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 245 | 125 | $7.46 | $1,828 |
| 80053 Clinical Chemistry | Office | 225 | 119 | $10.13 | $2,279 |
| 99215 Office E&M - Established | Office | 216 | 80 | $148.52 | $32K |
| 99233 Hospital E&M - Subsequent | Facility | 132 | 29 | $97.65 | $13K |
| 83615 Clinical Chemistry | Office | 131 | 65 | $5.73 | $751 |
| 99214 Office E&M - Established | Office | 105 | 67 | $101.87 | $11K |
| 99215 Office E&M - Established | Facility | 56 | 16 | $115.97 | $6,494 |
| 82784 Immunoassay | Office | 53 | 20 | $9.11 | $483 |
| 84100 Clinical Chemistry | Office | 41 | 19 | $4.17 | $171 |
| 82232 Clinical Chemistry | Office | 37 | 24 | $15.86 | $587 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 29 | 11 | $0.62 | $17.86 |
| 96365 Intravenous Infusion, Hydration | Office | 28 | 15 | $57.22 | $1,602 |
| 83735 Clinical Chemistry | Office | 27 | 15 | $5.70 | $154 |
| 96375 Injection Administration | Office | 27 | 12 | $13.84 | $374 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 20 | $13.72 | $371 |
By year: 2022 $400K for 12,592 services; 2023 $190K for 7,677 services; 2024 $271K for 11,646 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 245 | 125 | $7.46 | $1,828 |
| 80053 Clinical Chemistry | 225 | 119 | $10.13 | $2,279 |
| 83615 Clinical Chemistry | 131 | 65 | $5.73 | $751 |
| 82784 Immunoassay | 53 | 20 | $9.11 | $483 |
| 84100 Clinical Chemistry | 41 | 19 | $4.17 | $171 |
| 82232 Clinical Chemistry | 37 | 24 | $15.86 | $587 |
| 83735 Clinical Chemistry | 27 | 15 | $5.70 | $154 |
| 84550 Clinical Chemistry | 24 | 15 | $4.43 | $106 |
Medicare prescription drug claims, 2024
In 2024, the drug Patricia A Young prescribed most often to Medicare patients was Acyclovir, with 67 prescriptions and refills. In total Patricia A Young wrote 554 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 67 | 122 | 21 | $1,652 |
| Prednisone Generic | 42 | 42 | 11 | $102 |
| Lenalidomide Generic | 31 | 31 | Under 11 | $456K |
| Eliquis Apixaban | 27 | 50 | Under 11 | $24K |
| Venclexta Venetoclax | 23 | 23 | Under 11 | $297K |
| Onureg Azacitidine | 18 | 18 | Under 11 | $458K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 34 | Under 11 | $79.38 |
| Levofloxacin Generic | 15 | 15 | Under 11 | $57.64 |
| Allopurinol Generic | 15 | 19 | Under 11 | $65.35 |
| Hydroxyurea Generic | 15 | 41 | Under 11 | $467 |
| Brukinsa Zanubrutinib | 14 | 14 | Under 11 | $165K |
| Atovaquone Generic | 14 | 14 | Under 11 | $8,341 |
| Savaysa Edoxaban Tosylate | 13 | 13 | Under 11 | $4,882 |
| Imbruvica Ibrutinib | 13 | 13 | Under 11 | $249K |
| Xarelto Rivaroxaban | 12 | 12 | Under 11 | $6,464 |
Brand drugs: 174 claims; generic drugs: 380 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia A Young $24.84 ($24.84 in general payments such as food, travel and fees) from 8 companies. The largest payer was BeOne Medicines USA, Inc. with $24.84.
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. ONC | 1 | $24.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.